META Pharmaceuticals

META Pharmaceuticals Secures $14.8 Million to Advance Immuno-Metabolism Drug Development

Shenzhen-based META Pharmaceuticals Inc., a developer of immuno-metabolism targeted small molecules, has reportedly raised RMB...